Bicocca Open Archive

Logo unimib boa
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.276
AS - Asia 5.443
EU - Europa 4.826
SA - Sud America 884
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 133
OC - Oceania 19
Totale 23.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.672
SG - Singapore 1.944
CN - Cina 1.290
IT - Italia 841
HK - Hong Kong 797
DE - Germania 742
RU - Federazione Russa 732
BR - Brasile 683
VN - Vietnam 613
SE - Svezia 593
UA - Ucraina 542
CA - Canada 521
IE - Irlanda 471
GB - Regno Unito 223
FR - Francia 216
IN - India 154
FI - Finlandia 152
BD - Bangladesh 137
AT - Austria 112
AR - Argentina 79
KR - Corea 63
ID - Indonesia 61
TR - Turchia 57
NL - Olanda 48
IQ - Iraq 47
ZA - Sudafrica 46
PK - Pakistan 41
MX - Messico 39
SA - Arabia Saudita 38
JP - Giappone 35
CO - Colombia 29
CZ - Repubblica Ceca 28
EC - Ecuador 28
PH - Filippine 25
PL - Polonia 25
ES - Italia 24
UZ - Uzbekistan 23
VE - Venezuela 19
DK - Danimarca 17
EG - Egitto 17
BE - Belgio 13
CL - Cile 13
NP - Nepal 12
JM - Giamaica 11
MY - Malesia 11
PE - Perù 11
AU - Australia 10
PY - Paraguay 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
KE - Kenya 9
LB - Libano 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
AL - Albania 8
CR - Costa Rica 8
DZ - Algeria 8
KZ - Kazakistan 8
MA - Marocco 8
PS - Palestinian Territory 8
UY - Uruguay 8
AZ - Azerbaigian 7
ET - Etiopia 7
TT - Trinidad e Tobago 7
HN - Honduras 6
IL - Israele 6
TW - Taiwan 6
BG - Bulgaria 5
CH - Svizzera 5
IR - Iran 5
PT - Portogallo 5
RO - Romania 5
GR - Grecia 4
MD - Moldavia 4
OM - Oman 4
SN - Senegal 4
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LT - Lituania 3
NG - Nigeria 3
PA - Panama 3
BH - Bahrain 2
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
EU - Europa 2
LY - Libia 2
MU - Mauritius 2
MZ - Mozambico 2
NO - Norvegia 2
SC - Seychelles 2
SV - El Salvador 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 23.570
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.381
Woodbridge 1.161
Singapore 1.071
Ashburn 967
Fairfield 865
Hong Kong 791
Houston 778
Jacksonville 565
San Jose 529
Dublin 460
Chandler 456
Wilmington 368
Seattle 361
Dearborn 346
Toronto 333
Cambridge 302
Frankfurt am Main 270
Milan 270
New York 250
Beijing 240
Princeton 227
Ho Chi Minh City 188
Chicago 180
Council Bluffs 153
Santa Clara 149
The Dalles 145
Los Angeles 141
Hanoi 125
Nanjing 119
Hangzhou 110
Altamura 108
Shanghai 100
Vienna 98
Lachine 97
Lauterbourg 97
Lawrence 95
Moscow 84
Dallas 78
São Paulo 63
Buffalo 62
Rome 62
Seoul 59
Hefei 57
Nanchang 46
Helsinki 45
San Diego 39
Columbus 34
Shenyang 34
Ottawa 31
Dong Ket 30
Hebei 29
Jakarta 28
Jiaxing 28
Orem 28
Dhaka 27
London 27
Munich 27
Rio de Janeiro 27
Guangzhou 26
Haiphong 24
Brno 23
Jinan 23
Norwalk 23
Salt Lake City 23
Andover 22
Tokyo 22
Brooklyn 21
Da Nang 21
Tianjin 21
Boardman 20
Changsha 20
Falls Church 20
Tashkent 19
Warsaw 19
Amsterdam 18
Montreal 18
Jeddah 17
Ningbo 17
Phoenix 17
Mountain View 16
Tampa 15
Baghdad 14
Chennai 14
Fremont 14
Huizen 14
Atlanta 13
Belo Horizonte 13
Riyadh 13
Denver 12
Johannesburg 12
Miami 12
Naples 12
New Delhi 12
Newark 12
Quito 12
Redondo Beach 12
San Francisco 12
Brussels 11
Hải Dương 11
Kunming 11
Totale 15.542
Salva come PNG Salva come JPEG
Nome #
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 416
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 384
Clinical phenotypes in adult patients with bronchiectasis 340
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 327
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 324
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 314
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 312
Dyspnea in crackling lungs 310
Impact of traffic-related air pollution on pulmonary oxidative stress 306
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 304
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 300
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 298
A 61-year-old female with chronic cough and purulent sputum 294
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 291
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 285
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 277
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 275
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 274
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 272
The management of community-acquired pneumonia in the elderly 256
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 253
A 13-year-old female with shortness of breath and pleuritic chest pain 251
Individualizing duration of antibiotic therapy in community-acquired pneumonia 251
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 250
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 250
Prulifloxacin: A brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 249
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 249
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 249
Hospital admission decision for patients with community-acquired pneumonia 245
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 245
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 245
Mixed community-acquired lower respiratory tract infections 240
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 235
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF 230
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 230
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 229
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 229
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? 224
Azithromycin and lower respiratory tract infections 223
Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines 223
Do prognostic factors help physicians in predicting legionellosis' respiratory complications? 223
Chlamydophila pneumoniae 223
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 221
Chlamydia pneumoniae and acute aortic syndrome: A call for a multi-institutional study 219
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia 217
The bronchiectasis severity index. An international derivation and validation study 217
Pneumonia: how important are local epidemiology and smoking habits? 216
Strategic targets of essential host-pathogen interactions 214
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia 214
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 212
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia 212
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 210
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 210
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 210
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 207
Early application of non-invasive continuous positive airway pressure in acute respiratory distress syndrome due to a drug overdose: a case report 205
Noninvasive ventilation or continuous positive airway pressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates 205
100 years of respiratory medicine: pneumonia 204
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia 203
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): a two year study 202
Non-invasive-ventilation in H1N1 acute respiratory failure in emergency department: A case series 202
Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? 201
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 200
Compliance with anti-H1N1 vaccine among healthcare workers and general population 199
COPD and bronchiectasis: Phenotype, endotype or co-morbidity? 196
Validation of the 3CPO-score in a prospective cohort of Acute Cardiogenic Pulmonary Edema (ACPE) patients 196
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 195
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study 192
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia 189
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia 188
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia 187
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores 187
The management of patients with community-acquired pneumonia beyond antibiotic therapy 186
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 184
“Normotension” on admission to the emergency department affects outcome of patients with acute cardiogenic pulmonary edema (ACPE) 184
The role of biomarkers in low respiratory tract infections 182
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia 181
Impact of exacerbations in the natural course of COPD 181
Antibiotics as immunomodulant agents in COPD 180
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection 179
Acute exacerbation of COPD: application of evidence-based guidelines 179
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 178
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia 177
Chlamydia pneumoniae and Mycoplasma pneumoniae 176
Management of nontuberculous mycobacterial infection in the elderly 176
Is it time for a "pneumo-geriatrician" for frail old patients with respiratory diseases? 175
Telithromycin in lower respiratory tract infections 174
Cardiac diseases complicating community-acquired pneumonia 172
Healthcare-associated pneumonia: where do we go next? 171
Clinical applications of azithromycin microspheres in respiratory tract infections 171
Pneumococcal Vaccine and Patients with Pulmonary Diseases 171
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 169
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 169
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 163
Where are the acutely ill best cared for and who should look after them? 162
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study 158
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective 157
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia 156
Early outcomes in CAP: Clinical stability, clinical failure and nonresolving pneumonia 156
Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia. A prospective multicentre diagnostic accuracy study 155
Totale 22.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 102 104 90 52 103 55 61 64 86 93 198
2022/20231.833 250 532 224 133 92 315 9 90 133 4 25 26
2023/20241.249 35 32 47 31 172 335 254 57 153 15 10 108
2024/20252.827 205 348 76 141 275 60 82 79 313 474 326 448
2025/20267.557 694 427 538 874 777 401 999 442 626 685 503 591
2026/2027409 181 228 0 0 0 0 0 0 0 0 0 0
Totale 23.815